Medifast Inc reports results for the quarter ended in September 30 - Earnings Summary

Medifast

05/11/2024 07:42

* Medifast Inc  MED.N  reported quarterly adjusted earnings
of 35
cents​​ per share for the quarter ended September 30, lower than
the same quarter last year, when the company reported EPS of
$2.12.  The mean expectation of two analysts for the quarter was
for a loss of 28 cents per share. Wall Street expected
results to range from -40 cents to -15 cents per share.
    * Revenue fell 40.6% to $140.16 million from a year ago;
analysts
expected $134.15 million. 
    * Medifast Inc's reported EPS for the quarter was 10 cents​.
    * The company reported quarterly net income of $1.13
million.
    * Medifast Inc shares had fallen by 1.7% this quarter and
lost 72.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the food
processing
peer group is  "sell."

Wall Street's median 12-month price target for Medifast Inc is
$17.25 
This summary was machine generated from LSEG data November 5 at
07:42 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.28          0.35           Beat
 Jun. 30 2024      0.39           0.92           Beat
 Mar. 31 2024      0.78           0.66           Missed
 Dec. 31 2023      0.96           0.55           Missed